Guidance Recipients
Match would-be startups with local industry, academia, and related institutionsClinical Device for Antimicrobial Susceptibility Testing of Sepsis Pathogens
Cheng I-fang, National Applied Research Laboratories
Year 2020Year
Period:2020-11-01 to
Overview
- Upon confirmation of bacterial sepsis infection, administering the right antibiotics promptly may well save a life. At present, however, the workflow from blood culture to an AST report takes 2-3 days.
- The team has thus developed a general-purpose biochip system that can determine the bacterial cell density of blood samples as well as antimicrobial susceptibility and minimum inhibitory concentration within four hours.
- Provide doctors with precise information required for administering the right, promptly effective antibiotics, thereby reducing antibiotic resistance, increasing the patient survival rate, and mitigating nosocomial infection.
Development Process
Over the course of this project under the Applied Research Incubation Program, the team is set to complete research-type clinical trials and secure compliance with electrical safety regulations, as well as attain clinical efficacy essential agreement in excess of 90%.
Milestones
Project Leader
Project ManagerSabrina Wang SpecializationMolecular biology, signal transduction, microbial model building, protein purification, cancer pathology
More Professional Partners
sabrinawang@biip-mdcc.org
+886-3-658-8760#2031
Project Manager
Sabrina Wang
Specialization
Molecular biology, signal transduction, microbial model building, protein purification, cancer pathology
Duty
Guidance for teams focusing on IVD kits; drawing on her academic and professional expertise and understanding of applicable regulations to help academic or research teams commercialize their technologies and bring their products to market.
